Acurx Pharmaceuticals(ACXP) - 2024 Q3 - Quarterly Results

Exhibit 99.1 For Immediate Release — 7:01 am ET on Wednesday, November 13, 2024 Acurx Pharmaceuticals, Inc. Reports Third Quarter 2024 Results and Provides Business Update Staten Island, NY, November 13, 2024 — Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("we" or "Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today certain financial and operational results for the third quarter ended September 30, ...